Cell replacement therapies hold great therapeutic potential. Nevertheless, our knowledge of the mechanisms governing the developmental processes is limited, impeding the quality of differentiation protocols. Generating insulin-expressing cells in vitro is no exception, with the guided series of differentiation events producing heterogeneous cell populations that display mixed pancreatic islet phenotypes and immaturity. The achievement of terminal differentiation ultimately requires the in vivo transplantation of, usually, encapsulated cells. Here we show the impact of cell confinement on the pancreatic islet signature during the guided differentiation of alginate encapsulated human induced pluripotent stem cells (hiPSCs). Our results show that encapsulation improves differentiation by significantly reshaping the proteome landscape of the cells towards an islet-like signature. Pathway analysis is suggestive of integrins transducing the encapsulation effect into intracellular signalling cascades promoting differentiation. These analyses provide a molecular framework for understanding the confinement effects on hiPSCs differentiation while confirming its importance for this process.
Introduction
Differentiation of human pluripotent stem cells (hPSCs) into fully developed cell types holds a great therapeutic potential, especially the generation of hPSC-derived insulinproducing cells for cell therapy of diabetes. In mammals, pancreatic adult islets contain four hormone-secreting endocrine cell populations, each secreting only one specific hormone: insulin (β-cells), glucagon (α-cells), somatostatin (δ-cells), pancreatic polypeptide (PP-cells, γ -cells) and ghrelin (ε-cells). Multistep-protocols that mimic pancreas development have been designed for the generation of hPSC-derived insulinexpressing cells in vitro 1-3 .
Despite an increasing number of differentiation protocols, the efficient generation of a stable mature and functional insulin-producing β -cell is yet to be convincingly achieved 4 , 5
.
Moreover, most of these protocols do not restrict the cells towards β -cell fate exclusively, but rather generate cell entities resembling diverse hormone-secreting islet cell types. At final stages of differentiation, the generated cell populations are highly heterogeneous, with cells displaying variable levels or absence of key β -cell markers (such as PDX1 and NKX6.1) and a polyhormonal profile, resembling the transient endocrine cells observed in the fetal pancreas 6, 7 . Nevertheless, the reported heterogeneity grants certain advantages, as increasing evidence indicates that efficient glucose regulation requires proper arrangement and coordination between the various endocrine cell types found within the islets 8, 9 .
Therefore, recent research suggested focusing on in vitro generation of islets (i.e. all five cell populations) rather than aiming at differentiating cells into a single type of specialized cells 10 .
Currently, the final steps of β -cell maturation are achieved in vivo, by transplantation into mammalian hosts, such as mice. The cellular and molecular basis of the process driving this in vivo terminal differentiation is not yet completely understood 11 . Different potential scenarios include the involvement of circulating factors [12] [13] [14] [15] , nervous system association [16] [17] [18] and the presence of a 3D niche 19, 20 , amongst others. Discriminating the exact contribution of each of these potential scenarios on the transplanted hPSC-derived cells is difficult due to the inherent complexity of the organism environment.
Microencapsulation of islets into alginate microbeads was used first in the 1980s 21 , and was later employed in several studies for transplantation of pancreatic islets [22] [23] [24] [25] . Previous studies have reported that entrapment of hPSCs under the 3D environment of alginate microcapsules 26 supports long-term maintenance of pluripotency 27 and differentiation of dopamine neurons 28 , as well as pancreatic progenitors 29 . Alginate is recognized for
properties and characteristics such as its ability to make hydrogels at physiological conditions, transparency for microscopic evaluation, gel pore network that allows diffusion of nutrients and waste materials 30 , making alginate an attractive alternative for embedding hPSC-derived cells during differentiation.
In this study, we differentiated hiPSCs (human induced pluripotent stem cells) towards β like cells following a seven-stage protocol 1 , as we have reported previously 31 , to assess the impact of alginate encapsulation on islet cell differentiation potential during in vitro differentiation. Our data indicate that encapsulation of pancreatic endocrine progenitor efficiently improves the differentiation outcome by increasing both the proportion of hormone-positive cells and the fraction of insulin cells co-expressing key β -cell markers.
Moreover, encapsulation enables proteome adaptations of the differentiating cells towards a more islet-like fingerprint in a stage-specific manner, where the encapsulation of the first differentiation stages promotes early differentiation signals, while the encapsulation at a later differentiation stage promotes hormones and factors involved in hormone synthesis and secretion. Our results further suggest that these effects of alginate are relayed through integrins, which presumably translate the pressure elicited by the confinement of cells in the alginate matrix into signalling cascades.
RESULTS

Encapsulation promotes the expression of islet hormones and key islet transcriptional regulators
To investigate whether encapsulation had an impact on the differentiation outcome, we differentiated cells either on Matrigel-coated plates (representing a classical 2D culture condition) or encapsulated in alginate (representing a 3D platform for differentiation). Due to its high reproducibility and feasibility, we selected one of the most commonly employed protocol for β-cell differentiation designed by Rezania et al 1 , where hiPSC cells are differentiated gradually through a sequence of events involving 7-stages (Supp. Figure 1a ).
The dissociated cells before encapsulation displayed a viability of 90.96%±5.6, presenting homogeneous cell morphologies and no signs of proliferation or cluster formation within the alginate beads. Sporadic clumps of cells escaping the dissociating procedure were observed, however these did not present an ulterior different behaviour compared to single cells (Supp. Figure 1b , c). The alginate beads, presenting a radius of 375-500µm, were processed for immunofluorescence (IF) and high magnifications of whole mount encapsulated cells (Supp. Figure 1c ) and sections (Supp. Figure 1d ) revealed spherical cell morphology typical of single cells in suspension. To allow the quantification of the largest possible bead volume, we imaged for each whole mount bead a mosaic of 3x3 fields of view (FOV) over 100 different focal planes and performed a 3D reconstruction (Supp.
Figure 1e, f). Due to the large amount of data generated and also for excluding any potential counting-bias, we performed automatic quantification using Imaris 9. (3) at the final stage of the differentiation protocol, just before fixation, for consistency of imaging and counting (hereafter termed S7 bead[S7] ) ( Figure 1a , Supp. Figure 1a , b).
We first assessed the variation in the proportion of insulin-, glucagon-, and somatostatinexpressing cells following encapsulation (Figure 1b , c, f, Supp. Figure 2a ). A highly significant increase in the proportion of cells expressing insulin, glucagon, and somatostatin was observed when cells were encapsulated at the later stages of differentiation (S7 bead[S5-S7] ) as compared to the ones grown on Matrigel-coated plates (S7 bead [S7] ). The number of bihormonal cells was not significantly affected by encapsulation ( Figure 1c ). Interestingly, the cells encapsulated during the entire period of differentiation (S7 bead[S0-S7] ) displayed a significant increase of the glucagon-and somatostatin-expressing cell populations, but not insulin, as previously reported 29 .
We further assessed in all three conditions analysed the expression of the β -cells transcriptional regulators PDX1 and NKX6.1 (Figure 1d , e, g, Supp. Figure 2b) , two key factors involved in early pancreas development, endocrine compartment differentiation and β -cell fate [32] [33] [34] . Consistent with the previous results, the highest increase in the proportion of the PDX1-and NKX6.1-expressing cells was observed in the S7 bead[S5-S7] population (63.97%, Figure 1c 
Encapsulation promotes a large battery of proteins towards islet-like abundance levels
To comprehensively assess the encapsulation effect on the differentiation outcome, in a parallel and independent set of experiments, we performed global proteomics on differentiating hiPSC cells, which were grown either on Matrigel-coated plates (2D) or encapsulated in alginate (3D). To allow the investigation of the observed stage-dependent encapsulation effect, the cells were differentiated in capsules during (1) the early stages of (Figure 2a ).
These, their Matrigel-differentiating counterparts (S5 and S7) and native human islets isolated from deceased donors were compared by TMT 11-plex-based quantitative proteomics ( Figure 2b ). We quantified a total of 5364 proteins and focused our analysis on the proteins expressed in at least one sample of each condition (5029 proteins).
The hierarchical clustering revealed that encapsulated samples (S5 bead[S0-S5] and S7 bead[S5-S7] )
cluster closer to the human islets than their 2D culture condition differentiation-stage counterparts, with the S7 bead[S5-S7] samples being nearest ( Figure 2c ). These data suggest that encapsulation globally enhances the pancreatic endocrine cell fate, reinforcing the initial IF results.
Unfortunately, due to the inherent sensitivity limitation of the proteomics methods, we were unable to detect proteins with very low abundance, as displayed by many key pancreatic islet transcription factors, such as PDX1 or NKX6.1. Nevertheless, in consensus with our previous IF characterization, we observed a steep increase of all pancreatic islet hormones following encapsulation (Supp. Figure 3a ).
We further aimed to identify the proteins modulated towards an islet-like regulation in response to encapsulation. A simple comparison analysis between cells differentiating in capsules and their 2D culture counterparts would provide information about the general effects of encapsulation, but would fall short in identifying proteins relevant for differentiation towards islet cell phenotypes. Consequently, to discriminate the differentially-expressed proteins (DEPs) that in response to encapsulation are changing their abundance profiles towards the levels detected in islets from those with opposite regulation, we introduced the islet samples as normalization. We first filtered 3740 DEPs (FC≥1.5 p<0.05) between S5-cells and islets (Supp . Table 1) Furthermore, the number of proteins reaching abundance values similar to those exhibited by native islets was also increased by encapsulation, from 7.51% regulated in response to the differentiation cocktail alone to 21.71%, 27.67% and 27.18% when encapsulation influence was considered (Figure 2f, Supp. Table 2 ). Of note, the number of proteins presenting an islet-antagonizing pattern was decreasing in the three effects assessing the encapsulation involvement ( Figure 2f dark grey sectors, Supp. Figure 3c ).
Overall, these results suggest that, regardless of the iPSC differentiation stage, encapsulation was able to substantially modify the proteome landscape towards a more islet-like fingerprint, mostly by either maintaining or promoting lower abundance levels of certain proteins, which otherwise display an upregulated pattern in 2D-differentiated cells.
Pathway analysis reveals common proteome signatures in response to encapsulation
To identify the protein networks, signalling pathways and upstream regulators characterizing the improved islet-signature of the encapsulated differentiating cells in each of the four effects described above, we performed pathway analysis on the protein sets exhibiting islet-promoting regulation (Figure 3 , Supp. Figure 4a , c, e, g, Supp. Table 2 ). As a further refinement, we repeated the analysis on the protein sets reaching islet-like abundance levels in each dataset (Supp. Figure 4b , d, f, h). Taken together, these results indicate an expected improved differentiation status of the cells following the addition of the differentiation cocktails. Of note, the action of the differentiation protocol cocktails seems to mostly promote α -cell fate markers, a problem already described by previous studies involved in hormone synthesis and secretion were regulated towards islet-abundance values, including the main pancreatic islet-cells proconvertases PCSK1 (β-cell marker) and
IPA (Ingenuity
the main glucose transporter in humans, GLUT1 (SLC2A1) (Figure 3h ). As expected, the analysis of the protein subset displaying islet-like abundance values reinforced the involvement of the PI3K/AKT axis and mTOR Signaling in addition to HNF4A as a top predicted upstream regulator (Supp. Figure 4f, h) .
In conclusion, the encapsulation during the late stages of differentiation promotes the pancreatic-islet differentiated profile in S7-cells, exhibiting increased level of hormones and hormone proconvertases.
Overall, these results suggest that the Differentiation Cocktail Effect presented the most divergent signature of the protein set with islet-promoting regulation, while the three effects involving cell encapsulation exhibit rather related signatures. Moreover, the effect of encapsulation seems to have a stronger impact on the proteome profile of cells than the effect of the differentiation cocktail, as inferred from the Confounding Effect analysis.
Last, the Early Encapsulation Effect seems to be able to promote early differentiation signals towards islet cell fate, while the Late Encapsulation effect promotes hormones and factors involved hormone synthesis and secretion, hence boosting the differentiated isletcell profile.
Encapsulation and the differentiation cocktail promote different protein sets
To identify whether encapsulation acts on the same targets as the differentiation cocktail, we first filtered for proteins exhibiting islet-promoting regulation shared by Differentiation Cocktail Effect, Early Encapsulation Effect and Late Encapsulation Effect (Figure 4a , left panel, Supp. Table 3 ). We identified only 210 proteins as being regulated by all three effects, representing 25.5%, 8.2% and 6.9% of the respective protein sets, with the pathway analysis retrieving mainly metabolic pathways.
The same Venn comparison revealed 294 proteins being regulated exclusively by the Differentiation Cocktail and Early Encapsulation effects (Figure 4a , middle panel, Supp. Encapsulation effects, contained 69 proteins (Figure 4a , right panel, Supp. Table 3 ). The pathway analysis strength was limited due to the very low number of proteins in this profile, however it contained several key pancreatic-islet markers among which GCG, IAPP and CHGB (chromogranin B).
These data indicated that the encapsulation and the differentiation cocktail largely regulate different targets. The encapsulation during early stages of differentiation shared the largest number of proteins exhibiting islet-promoting regulation with the effect of the differentiation cocktail, suggesting once more that encapsulation alone can, at least in some extent, promote the pancreatic islet-cell differentiation. Furthermore, the boost of key mature islet-cell markers induced by the differentiation cocktail reinforces the role of encapsulation during the later stages of differentiation in boosting the differentiated isletcell signature.
Encapsulation effects on differentiation are stage-specific
To compare further the Early and Late Encapsulation effects, we first performed pathway analysis on the shared group of proteins exhibiting islet-promoting regulation (Figure 4b , left panel, Supp. Table 3 36 .
All these results suggest that encapsulation treatment is a driving force promoting β -cell fate by both promoting differentiation at early stages and potentiating the differentiated islet signature during the last, confirming our initial IF results.
Pathway analysis is suggestive of encapsulation regulating the proteome landscape via integrins
Last, we wanted to characterize the general effects and targets of encapsulation, independent of its action on promoting the pancreatic islet cell fate. For this purpose, we Figure 5a) . Moreover, we also detected in the top pathways the growth regulating HIPPO pathway (predicted as activated) and the 14-3-3 Signalling pathway (predicted as inactivated) (Supp. Figure 5d Overall, these results suggested that encapsulation acts during iPSC differentiation through integrins, which probably translate the pressure elicited by the confinement of cells in the alginate matrix into signalling cascades. Of note, these pathways patterns of regulation are consistent with previously published reports 37 , in which their involvement in promoting β cell differentiation in a different system (micropatterned slides) was proposed, suggesting a general role of the pressure-integrin axis in promoting cell differentiation in confined structures. In this study, our goal was to characterize the specific effects of the encapsulation on the differentiation potential by studying its impact on the differentiating cells proteome fingerprint during either early or late differentiation. In order to eliminate any interference from a possible aggregation/cell clustering effect, we focused on the encapsulation of single cells. This is in contrast with previous studies, which deliberately used clusters to assess the alginate encapsulation effect 29 . We showed here for the first time that The general impact of the 3D organization for the cell differentiation potential is also supported by the introduction of air liquid interface 1 or suspension culture 46 Our subsequent proteome analyses suggested that encapsulation strongly boosts β -cell fate in a stage-specific manner, by promoting early-stage differentiation and potentiating the islet signature during the later stages. To our knowledge, this is the first comparison by global proteomics of encapsulated and Matrigel differentiating cells. In differentiating encapsulated cells, a large batch of proteins is regulated towards islet cell fate with a significant fraction reaching abundance values similar with islet. We detected a high degree of overlap in the protein populations regulated by encapsulation during early and late regeneration, suggesting that these generally respond to 3D culturing conditions independent of the differentiation stage. We further pinpointed the regulation of growth pathways such as the mTOR signalling, the involvement of the PI3K/AKT axis as well as the INSR signalling in response to encapsulation. The INSR regulatory network is regulated in response to encapsulation during late differentiation specifically, while the PI3K/AKT axis seems to be part of the pathways modulated mostly in cells encapsulated early during differentiation.
DISCUSSION
It was demonstrated recently that cell confinement is mandatory for endocrine cell specification during development and it negatively regulates the activity of the mechanoresponsive transcription factor YAP1 through a mechanism involving an integrin Moreover, we expect that our data will contribute to demultiplexing the intricate outcome of the in vivo environment following the transplantation of encapsulated cells, by helping to exclude the protein profiles characterizing the confinement effect inherent to encapsulation.
MATERIALS AND METHODS
Cell sources
We used human induced pluripotent stem cells previously generated via episomal reprogramming 31 from skin fibroblasts collected from a healthy donor. Prior to starting in vitro differentiation, the hiPSCs line was enriched for SSEA4 + cells using magnetic beads (MACS Miltenyi Biotec), and tested negative for mycoplasma. Human islets were obtained as previously 49 described from one male and three female deceased donors (age 52-63).
In vitro differentiation
The normal healthy hiPSC line (2 million cells per condition) was differentiated as described previously 31 following a seven-stage differentiation protocol 1 in planar culture conditions (on Matrigel-coated plates) up to stage S5 (pancreatic endocrine precursor) and/or stage S7 (maturing beta-cells). 5 million cells were embedded in alginate beads at S0 (hiPSCs) or S5, respectively (Experimental design Suppl. Fig. 1b ).
Encapsulation in alginate beads
We used ultra-pure LVG (70 % G and 198 mPas) sodium alginate (batch #BP-0907-02, FMC BioPolymer AS NovaMatrix, Norway) for encapsulation of hiPSC (S0) and S5 cells. Fig. 1b) . 
Cell viability and count
Confocal Imaging
Whole mount beads were imaged using the Andor Dragonfly 5050 (Andor Technologies, Inc) confocal microscope with an 20x dry objective (CFI Plan Apochromat Lambda 20x).
Each bead was imaged with 3x3 fields of view, which covered the entire bead. 
Global proteomics analysis
Non-encapsulated hiPSC-derived cells were washed in DPBS and harvested with TrypLE™ Select Enzyme (1X) (12563011, Thermo Fisher Scientific), and collected by centrifugation. Human islets were processed as previously described 31, 51 , more specifically here four islet samples representing 200 handpicked equally-sized islets per donor (described above) were combined and mixed to make a homogenous mixture, and 15 μ g protein of the mix were divided into three separate samples for downstream analysis. Encapsulated cells were lysed directly in the alginate beads, in a buffer containing 8M Urea, 200 mM EPPS pH8.5 and protease inhibitors (Roche complete with EDTA), and sonicated (30 seconds x 3 times at 30% power). Chloroform-Methanol precipitation was performed as previously described 52 . The protein concentration was measured by using a BCA protein assay kit. Samples containing an estimated amount of 15 µg of total protein were processed as described previously 31, 51 . 
Figure legends
